Characterization of the Neutralizing Activity of Digoxin-Specific Fab toward Ouabain-Like Steroids
Characterization of the Neutralizing Activity of Digoxin-Specific Fab toward Ouabain-Like Steroids
复制标题
地高辛特异性 Fab 对哇巴因样类固醇的中和活性的表征
DOI:
10.1124/jpet.104.065250
复制
发表时间:
2004
影响因子:
3.5
通讯作者:
R. Edwards
中科院分区:
文献类型:
--
作者:
M. Pullen;D. Brooks;R. Edwards
Digoxin-specific Fab (Digibind) is a mixture of antidigoxin Fab fragments prepared from sheep sera and is used as a treatment for digoxin poisoning. Digoxin-specific Fab has been shown to neutralize an endogenous Na+/K+ ATPase inhibitor (endogenous digoxin-like Na+/K+ ATPase regulatory factor; EDLF) in rats and humans and to lower blood pressure. Although the exact structure of EDLF is unknown, compounds identical to or structurally related to ouabain, bufalin, and marinobufagenin have been detected in mammalian plasma. In this study, some structural characteristics of EDLF were inferred from the ability of digoxin-specific Fab to neutralize the Na+/K+ ATPase inhibitory activity of several known cardenolides and bufodienolides. Additional structural information was obtained from [3H]ouabain binding and enzyme-linked immunosorbent assay experiments. Digoxin-specific Fab had the ability to interact to some extent with all of the cardenolides and bufodienolides tested. However, digoxin-specific Fab was more than 20-fold more potent in neutralizing ouabain and bufalin than marinobufagenin. The antihypertensive effect of digoxin-specific Fab seen in preeclampsia and animal models of hypertension may therefore be due to a molecule identical to or structurally similar to ouabain or bufalin.
登录
查看更多内容
影响因子:
3.2
作者:
Graves,SW;Lincoln,K;Cook,SL;Seely,EW
通讯作者:
Seely,EW
DOI:
10.1152/ajpcell.1998.275.4.c1167
发表时间:
1998
期刊:
The American journal of physiology
影响因子:
--
作者:
Yingst,DR;Yang,SY;Schiebinger,R
通讯作者:
Schiebinger,R
影响因子:
8.3
作者:
O. Fedorova;N. I. Kolodkin;N. Agalakova;E. Lakatta;A. Bagrov
通讯作者:
O. Fedorova;N. I. Kolodkin;N. Agalakova;E. Lakatta;A. Bagrov
影响因子:
7.3
作者:
Farr, CD;Tabet, MR;Welsh, WJ
通讯作者:
Welsh, WJ
影响因子:
9.3
作者:
M. A. El-Masri;B. Clark;H. Qazzaz;R. Valdes
通讯作者:
M. A. El-Masri;B. Clark;H. Qazzaz;R. Valdes